Story Navigation
-
DiscoveryAccess to HealthcareChildren's HealthDisease EradicationInfectious DiseasesNovartis Social BusinessThe specter of malaria that resists treatment
Great progress has been made against malaria, but signs of resistance are becoming a rising concern
Discovery -
DiscoveryNovartis Institutes for BioMedical ResearchReimagine MedicineTargeted TherapyBiomedical JobsLoss of friend to liver cancer sharpens focus on experimental therapy
A Novartis experimental drug in clinical trial aims to block liver cancer growth
Discovery -
DiscoveryNovartis Institutes for BioMedical ResearchOncologyWomen in ScienceWorking at NovartisWomen in Science: Annie Martin
Our Global Head of Precision Medicine in Oncology discusses her day-to-day work at Novartis.
Discovery -
From Our LabsNovartis Institutes for BioMedical ResearchClinical ResearchClinical TrialsCould digital technology drive clinical research in Africa?
Novel digital platform for clinical trial data collection could help facilitate much-needed biomedical research in lower-income countries.
From Our Labs -
DiscoveryNovartis Institutes for BioMedical ResearchResearch JobsCancer Research InstituteBiomedical ScienceEyewitness to a healer pursues new treatments for patients
Inspired by her mother, Vicky Qi leads drug discovery teams.
Discovery -
DiscoveryAccess to HealthcareBiomedical ResearchCancerChronic IllnessDiseasesStriving to vanquish leukemia
Combination of two compounds shows promise in the lab
Discovery -
Patient PerspectivesCancerLiving With DiseaseOncologyPatient EducationPatient VoicesInside a cancer diagnosis
Melanoma survivor T.J. Sharpe shares key insights about the cancer diagnosis experience.
Patient Perspectives -
Patient PerspectivesDisease AwarenessOncologyRare DiseasesRare Every Day: Experiences, challenges and victories of the rare disease communityPatient Perspectives
-
Patient PerspectivesCancerOncologyPatient VoicesSocial CommitmentTargeted TherapyClinical TrialsMeet T.J. Sharpe
Meet Melanoma survivor TJ Sharpe in the first installment of his new blog series on Novartis.com.
Patient Perspectives -
From Our LabsBiomedical ResearchNovartis Institutes for BioMedical ResearchReimagine MedicineNew Scientific DiscoveriesDrug DesignCountering the genome reprogramming of cancer cells
Novel PRC2 inhibitor changes the expression of hundreds of genes in lab model
From Our Labs -
DiscoveryOncologyWomen in ScienceWorking at NovartisCareersWomen in Science: Virginia Lazala
Lazala has been recognized by Hispanic Executive magazine for her commitment to mentoring students and colleagues.
Discovery -
Patient PerspectivesChronic IllnessDiseasesLiving With DiseaseRespiratoryA New Year’s resolution for COPD
Discover how COPD assessment and treatment are changing.
Patient Perspectives
Pagination
- ‹ Previous page
- 1
- …
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- …
- 32
- › Next page